Related Experiment Video

Updated: Jun 29, 2025

Author Spotlight: Innovative Use of nsPEF to Boost Peripheral Nerve Regeneration
09:24

Author Spotlight: Innovative Use of nsPEF to Boost Peripheral Nerve Regeneration

Published on: May 3, 2024

743

Fas ligand regulate nerve injury and repair by affecting AKT, β-catenin, and NF-κB pathways

Yiyue Zhou1, Yi Yao2, Yumei Feng1

  • 1School of Life Sciences, Jiangsu Key Laboratory of Neuroregeneration, Co-innovation Center of Neuroregeneration, Nantong University, 19 Qixiu Road, Nantong, Jiangsu 226001, China.

IBRO Neuroscience Reports
|March 28, 2024
PubMed
Abstract

Insights

Fas-L down-regulation after sciatic nerve injury promotes nerve regeneration and inhibits apoptosis in rats. Modulating Fas-L offers potential for peripheral nerve repair and functional reconstruction.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Regenerative Medicine

Background:

  • Peripheral nerve injuries pose significant challenges to functional recovery.
  • Understanding the molecular mechanisms regulating nerve repair is crucial for developing effective treatments.

Purpose of the Study:

  • To investigate the regulatory role of Fas-L in peripheral nerve repair and regeneration.
  • To explore the impact of Fas-L on apoptosis and axonal regeneration in dorsal root ganglion (DRG) cells.

Main Methods:

  • Utilized an animal model of sciatic nerve injury in Sprague Dawley (SD) rats.
  • Employed cell biology and molecular biology techniques to analyze DRG cells.
  • Investigated the effects of manipulating Fas-L expression on nerve regeneration and apoptosis.

Main Results:

  • Fas-L expression was significantly downregulated in DRG tissues post-sciatic nerve injury.
  • Interference with Fas-L promoted axonal regeneration and inhibited apoptosis.
  • Overexpression of Fas-L had the opposite effect, hindering regeneration and promoting apoptosis.
  • Fas-L influences DRG function and peripheral nerve repair via signaling pathways including p-AKT/AKT, β-catenin, and NF-κB.

Conclusions:

  • Fas-L plays a regulatory role in peripheral nerve injury repair and regeneration in SD rats.
  • Modulating Fas-L expression presents a potential therapeutic strategy for functional reconstruction of peripheral nerves.
Keywords:
ApoptosisDRG neuronsFas-LNerve degenerationNerve injuryNerve regenerationPeripheral nerves

More Related Videos

The Fibular Nerve Injury Method: A Reliable Assay to Identify and Test Factors That Repair Neuromuscular Junctions06:01

The Fibular Nerve Injury Method: A Reliable Assay to Identify and Test Factors That Repair Neuromuscular Junctions

Published on: August 11, 2016

15.8K
Genetic Study of Axon Regeneration with Cultured Adult Dorsal Root Ganglion Neurons09:42

Genetic Study of Axon Regeneration with Cultured Adult Dorsal Root Ganglion Neurons

Published on: August 17, 2012

26.7K

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.4K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.3K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.7K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.4K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.5K